Jaguar Health JAGX Income Statement (2014-2026)

NASDAQ JAGX
$5.32 -0.70 (-11.63%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Jaguar Health Quarterly Income Statement

Periods 50 quarters
Latest Jun 2026

Jaguar Health reported revenue of $1.23M and net income of -$12.80M for the quarter ended Jun 2026, down 58.9% year over year. This income statement covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.63M2.08M2.62M2.92M3.15M3.26M1.97M2.68M2.81M2.30M2.35M2.72M3.11M3.51M2.21M2.98M3.08M3.23M20.27M1.23M
Cost of RevenueCost of Rev
0.62M0.47M0.46M0.46M0.61M0.49M0.34M0.49M0.51M0.69M0.43M0.43M0.54M0.56M0.52M0.53M0.53M2.20M1.16M1.03M
Gross Profit
0.01M1.61M2.17M2.46M2.54M2.77M1.63M2.19M2.30M1.61M1.92M2.29M2.57M2.95M1.70M2.45M2.55M1.03M19.11M0.19M
Operating items
Research & DevelopmentR&D
3.31M5.48M4.95M2.45M5.94M4.31M4.78M4.28M6.08M3.46M4.31M3.65M4.04M4.53M3.73M3.27M3.66M14.31M3.93M3.34M
Selling, General & AdministrativeSG&A
3.97M4.65M6.14M4.35M4.38M2.99M4.81M4.44M3.53M3.81M4.38M4.31M3.78M3.86M4.90M4.73M4.13M4.89M4.11M4.45M
Other Operating ExpensesOther Opex
2.88M2.77M3.29M2.60M2.72M2.24M2.23M2.06M1.99M2.59M1.87M1.95M2.55M3.27M3.01M2.99M2.53M5.28M2.05M1.04M
Operating ExpensesOpex
10.16M12.90M14.38M9.40M13.05M9.55M11.82M10.78M11.60M9.86M10.57M9.92M10.37M11.67M11.63M10.99M10.32M24.48M10.09M8.82M
Operating IncomeOp. Inc
-9.53M-10.82M-11.75M-6.48M-9.90M-6.29M-9.85M-8.10M-8.79M-7.56M-8.21M-7.20M-7.26M-8.16M-9.42M-8.01M-7.24M-21.24M10.18M-7.60M
EBIT
-9.53M-10.82M-11.75M-6.48M-9.90M-6.29M-9.85M-8.10M-8.79M-7.56M-8.21M-7.20M-7.26M-8.16M-9.42M-8.01M-7.24M-21.24M10.18M-7.60M
Non-operating items
Non Operating Interest Expenses
2.08M2.43M4.19M2.54M2.73M2.63M2.18M3.45M0.50M0.25M0.61M-0.11M-0.16M-0.11M-0.06M-0.01M0.01M0.13M0.70M0.16M
Goodwill impairment chargesGoodwill Impair.
Other Non Operating IncomeOther Non Op Inc.
-0.02M-0.01M-2.81M-1.08M-0.16M-0.01M0.03M3.70M1.25M-0.73M0.17M0.11M-1.82M-0.09M0.02M-0.63M-3.50M
Net income details
EBT
-12.19M-14.32M-18.16M-9.39M-12.61M-8.23M-12.40M-12.29M-7.90M-9.31M-9.37M-9.63M-10.02M-10.23M-10.60M-10.56M-9.65M-23.19M8.72M-12.80M
Tax ProvisionsTaxes
Profit After TaxPAT
-12.19M-14.32M-18.16M-9.39M-12.61M-8.23M-12.40M-12.29M-7.90M-9.31M-9.37M-9.63M-10.02M-10.23M-10.60M-10.56M-9.65M-23.19M8.72M-12.80M
Income from Non-Controlling InterestsInc. Minority
-0.18M-0.02M-0.09M-0.65M-0.20M-0.14M-0.13M-0.14M-0.14M-0.14M-0.13M-0.15M-0.13M-0.12M
Income from Continuing OperationsIncome (Continuing)
-12.19M-14.32M-18.16M-9.39M-12.61M-8.23M-12.40M-12.29M-7.90M-9.31M-9.37M-9.63M-10.02M-10.23M-10.60M-10.56M-9.65M-23.19M8.72M-12.80M
Consolidated Net IncomeConsol Net Inc.
-12.19M-14.32M-18.16M-9.39M-12.61M-8.23M-12.40M-12.29M-7.90M-9.31M-9.37M-9.63M-10.02M-10.23M-10.60M-10.56M-9.65M-23.19M8.72M-12.80M
Income towards Parent CompanyParent Net Inc
-12.19M-14.32M-18.16M-9.39M-12.61M-8.23M-12.40M-12.29M-7.90M-9.31M-9.37M-9.63M-10.02M-10.23M-10.60M-10.56M-9.65M-23.19M-0.01M0.04M
Preferred Dividend PaymentsPref Dividends
6.06M0.01M
Net Income towards Common StockholdersNet Income
-12.19M-14.31M-17.99M-9.37M-12.52M-7.58M-12.20M-12.15M-7.78M-9.17M-9.23M-9.49M-10.02M-10.23M-10.46M-10.41M-9.65M-23.19M-7.01M-12.70M
Additional items
EPS (Basic)
-239.32-288.05-361.97-0.01M-0.01M-0.01M-0.00M-620.09-337.47-357.69-52.26-60.60-16.04-521.19-250.48-153.83-95.64-149.16-204.01-235.46
EPS (Diluted)
-239.32-0.02M-0.02M-0.01M-0.01M-0.01M-0.00M-375.58-337.47-357.69-52.26-60.60-16.04-521.19-250.48-153.83-95.64-149.16-204.01-235.46
Shares Outstanding
0.05M0.05M0.05M0.00M0.00M0.00M0.01M0.02M0.02M0.03M0.18M0.16M0.62M0.02M0.04M0.07M0.10M0.16M0.03M0.05M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.05M663.00865.000.00M0.00M0.00M0.01M0.03M0.02M0.03M0.18M0.16M0.62M0.02M0.04M0.07M0.10M0.16M0.03M0.05M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.05M0.05M0.05M0.00M0.00M0.00M0.01M0.02M0.03M0.03M0.18M0.16M0.69M0.16M0.16M0.16M0.16M0.16M0.16M0.16M
EBITDA
-9.10M-10.39M-11.33M-5.92M-9.40M-5.79M-9.34M-7.60M-8.28M-7.05M-7.71M-6.75M-6.79M-7.68M-8.94M-7.53M-6.76M-20.77M10.65M-7.12M
Interest ExpensesInt Expense
2.08M2.43M4.19M2.54M2.73M2.63M2.18M3.45M0.50M0.25M0.61M-0.11M-0.16M-0.11M-0.06M-0.01M0.01M0.13M0.70M0.16M

Jaguar Health Income Statement API

Pull Jaguar Health's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=JAGX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY